The 50-Year History, Controversy, and Clinical Implications of Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy. From Idiopathic Hypertrophic Subaortic Stenosis to Hypertrophic Cardiomyopathy

Journal of the American College of Cardiology

Volumn 54, Issue 3, 2009, Pages 191-200

  Maron, Barry J ^a   Maron, Martin S ^b   Wigle, E Douglas ^d   Braunwald, Eugene ^c  

^a MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

cardiac surgery; cardiomyopathies; heart catheterization; heart failure; heart failure treatment; hypertrophic; hypertrophy

Indexed keywords

AORTA SUBVALVULAR STENOSIS; DOPPLER ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MORTALITY; MUSCLE RESECTION; MYOTOMY; PRIORITY JOURNAL; REVIEW;

CARDIOMYOPATHY, HYPERTROPHIC; HEART CATHETERIZATION; HEART FAILURE; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; PROGNOSIS; TIME FACTORS; VENTRICULAR OUTFLOW OBSTRUCTION;

EID: 67649628989     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.11.069     Document Type: Review

References (100)

1. Brock R.C. Functional obstruction of the left ventricle (acquired aortic subvalvar stenosis). Guys Hosp Rep 106 (1957) 221
2. Teare D. Asymmetrical hypertrophy of the heart in young adults. Br Heart J 20 (1958) 1-8
3. Morrow A.G., and Braunwald E. Functional aortic stenosis. A malformation characterized by resistance to left ventricular outflow without anatomic obstruction. Circulation 20 (1959) 181-189
4. Braunwald E., Lambrew C.T., Rockoff S.D., Ross Jr. J., and Morrow A.G. Idiopathic hypertrophic subaortic stenosis. I. A description of the disease based upon an analysis of 64 patients. Circulation 29 Suppl 4 (1964) 3-119
5. Maron B.J., McKenna W.J., Danielson G.K., et al. ACC/ESC clinical expert consensus document on hypertrophic cardiomyopathy: a report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines (Committee to Develop an Expert Consensus Document on Hypertrophic Cardiomyopathy). J Am Coll Cardiol 42 (2003) 1687-1713
6. Spirito P., Seidman C.E., McKenna W.J., and Maron B.J. The management of hypertrophic cardiomyopathy. N Engl J Med 336 (1997) 775-785
7. Wigle E.D., Sasson Z., Henderson M.A., et al. Hypertrophic cardiomyopathy: the importance of the site and the extent of hypertrophy: a review. Prog Cardiovasc Dis 28 (1985) 1-83
8. Maron B.J. Hypertrophic cardiomyopathy: a systematic review. JAMA 287 (2002) 1308-1320
9. Goodwin J.F. The frontiers of cardiomyopathy. Br Heart J 48 (1982) 1-18
10. Frank S., and Braunwald E. Idiopathic hypertrophic subaortic stenosis. Clinical analysis of 126 patients with emphasis on the natural history. Circulation 37 (1968) 759-788
11. McKenna W.J., and Behr E.R. Hypertrophic cardiomyopathy: management, risk stratification and prevention of sudden death. Heart 87 (2002) 169-176
12. Maron B.J., Bonow R.O., Cannon R.O., Leon M.B., and Epstein S.E. Hypertrophic cardiomyopathy: interrelation of clinical manifestations, pathophysiology, and therapy. N Engl J Med 316 (1987) 780-9, 844-52
13. Elliott P., and McKenna W.J. Hypertrophic cardiomyopathy. Lancet 363 (2004) 1881-1891
14. Maron B.J. Hypertrophic cardiomyopathy. Lancet 350 (1997) 127-133
15. Wigle E.D., Rakowski H., Kimball B.P., and Williams W.G. Hypertrophic cardiomyopathy. Clinical spectrum and treatment. Circulation 92 (1995) 1680-1692
16. Seidman J.G., and Seidman C.E. The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell 104 (2001) 557-567
17. Brachfield N., and Gorlin R. Functional subaortic stenosis. Ann Intern Med 54 (1961) 1-11
18. Braunwald E., Morrow A.G., Cornell W.P., Aygen M.M., and Hilbish T.F. Idiopathic hypertrophic subaortic stenosis: clinical, hemodynamic and angiographic manifestations. Am J Med 29 (1960) 924-935
19. Wigle E.D., Heimbecker R.O., and Gunton R.W. Idiopathic ventricular septal hypertrophy causing muscular subaortic stenosis. Circulation 26 (1962) 325-340
20. Criley J.M., Lewis K.B., White R.I., and Ross R.S. Pressure gradients without obstruction: a new concept of "hypertrophic subaortic stenosis.". Circulation 32 (1964) 881-887
21. Criley J.M., and Siegel R.J. Has "obstruction" hindered our understanding of hypertrophic cardiomyopathy?. Circulation 72 (1985) 1148-1154
22. Murgo J.P., Alter B.R., Dorethy J.F., Altobelli S.A., and McGranahan Jr. G.M. Dynamics of left ventricular ejection in obstructive and nonobstructive hypertrophic cardiomyopathy. J Clin Invest 66 (1980) 1369-1382
23. Murgo J.P. Does outflow obstruction exist in hypertrophic cardiomyopathy?. N Engl J Med 307 (1982) 1008-1009
24. Braunwald E., Brockenbrough E.C., and Morrow A.G. Hypertrophic subaortic stenosis-a broadened concept (editorial). Circulation 26 (1962) 161-165
25. Braunwald E., and Aygen M.M. Idiopathic myocardial hypertrophy without congestive heart failure or obstruction to blood flow: clinical, hemodynamic and angiocardiographic studies in fourteen patients. Am J Med 35 (1963) 7-19
26. Abbasi A.S., MacAlpin R.N., Eber L.M., and Pearce M.L. Echocardiographic diagnosis of idiopathic hypertrophic cardiomyopathy without outflow obstruction. Circulation 46 (1972) 897-904
27. Henry W.L., Clark C.E., and Epstein S.E. Asymmetric septal hypertrophy. Echocardiographic identification of the pathognomonic anatomic abnormality of IHSS. Circulation 47 (1973) 225-233
28. Abbasi A.S., MacAlpin R.N., Eber L.M., and Pearce M.L. Left ventricular hypertrophy diagnosed by echocardiography. N Engl J Med 389 (1973) 118-121
29. Shah P.M., Gramiak R., and Kramer D.H. Ultrasound localization of left ventricular outflow obstruction in hypertrophic obstructive cardiomyopathy. Circulation 40 (1969) 3-11
30. Shah P.M., Gramiak R., Adelman A.G., and Wigle E.D. Role of echocardiography in diagnostic and hemodynamic assessment of hypertrophic subaortic stenosis. Circulation 44 (1971) 891-898
31. Pridie R.B., and Oakley C. Mitral valve movement in hypertrophic obstructive cardiomyopathy. Br Heart J 31 (1969) 390
32. Braunwald E., and Ebert P.A. Hemodynamic alterations in idiopathic hypertrophic subaortic stenosis induced by sympathomimetic drugs. Am J Cardiol 10 (1962) 489-495
33. Gilligan D.M., Chan W.L., Ang E.L., and Oakley C.M. Effects of a meal on hemodynamic function at rest and during exercise in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 18 (1991) 429-436
34. Paz R., Jortner R., Tunick P.A., et al. The effect of the ingestion of ethanol on obstruction of the left ventricular outflow tract in hypertrophic cardiomyopathy. N Eng J Med 335 (1996) 938-941
35. Maron M.S., Olivotto I., Zenovich A.G., et al. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation 114 (2006) 2232-2239
36. Wigle E.D., Lenkei S.C., Chrysohou A., and Wilson D.R. Muscular subaortic stenosis: the effect of peripheral vasodilatation. Can Med Assoc J 89 (1963) 896-899
37. Sherrid M.V., Barac I., McKenna W.J., et al. Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 45 (2005) 1251-1258
38. Ciró E., Maron B.J., Bonow R.O., Cannon R.O., and Epstein S.E. Relation between marked changes in left ventricular outflow tract gradient and disease progression in hypertrophic cardiomyopathy. Am J Cardiol 53 (1984) 1103-1109
39. Harris K.M., Spirito P., Maron M.S., et al. Prevalence, clinical profile and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy. Circulation 114 (2006) 216-225
40. Panza J.A., Maris T.J., and Maron B.J. Development and determinants of dynamic obstruction to left ventricular outflow in young patients with hypertrophic cardiomyopathy. Circulation 85 (1992) 1398-1405
41. Maron B.J., and Epstein S.E. Hypertrophic cardiomyopathy: a discussion of nomenclature. Am J Cardiol 43 (1979) 1242-1244
42. Ross Jr. J., Braunwald E., Gault J.H., Mason D.T., and Morrow A.G. The mechanism of the intraventricular pressure gradient in idiopathic hypertrophic subaortic stenosis. Circulation 34 (1966) 558-578
43. Wigle E.D., Marquis Y., and Auger P. Muscular subaortic stenosis: initial left ventricular inflow tract pressure in the assessment of intraventricular pressure differences in man. Circulation 35 (1967) 1100-1117
44. Wilson W.S., Criley J.M., and Ross R.S. Dynamics of left ventricular emptying in hypertrophic subaortic stenosis: a cineangiographic and hemodynamic study. Am Heart J 73 (1967) 4-16
45. Wigle E.D., Auger P., and Marquis Y. Muscular subaortic stenosis. The direct relation between the intraventricular pressure difference and the left ventricular ejection time. Circulation 36 (1967) 36-44
46. Maron B.J., and Epstein S.E. Clinical significance and therapeutic implications of the left ventricular outflow tract pressure gradient in hypertrophic cardiomyopathy. Am J Cardiol 58 (1986) 1093-1096
47. Morrow A.G., Lambrew C.T., and Braunwald E. Idiopathic hypertrophic subaortic stenosis. II. Operative treatment and the results of pre and postoperative hemodynamic evaluations. Circulation 30 Suppl 4 (1964) 120-151
48. Simon A.L., Ross J., and Gault J.H. Angiographic anatomy of the left ventricle and mitral valve in idiopathic hypertrophic subaortic stenosis. Circulation 38 (1967) 852-867
49. Morrow A.G., and Brockenbrough E.C. Surgical treatment of idiopathic hypertrophic subaortic stenosis. Ann Surg 154 (1961) 181-189
50. Kirklin J.W., and Willis F.H. Surgical relief of diffuse subvalvular aortic stenosis. Circulation 24 (1961) 739-742
51. Wigle E.D., Chrysohou A., and Bigelow W.G. Results of ventriculomyotomy in muscular subaortic stenosis. Am J Cardiol 11 (1963) 572-586
52. Henry W.L., Clark C.E., Glaney D.L., and Epstein S.E. Echocardiographic measurement of the left ventricular outflow gradient in idiopathic hypertrophic subaortic stenosis. N Engl J Med 288 (1973) 989-993
53. Henry W.L., Clark C.E., Griffith J.M., and Epstein S.E. Mechanism of left ventricular outflow obstruction in patients with obstructive asymmetric septal hypertrophy (idiopathic hypertrophic subaortic stenosis). Am J Cardiol 35 (1975) 337-345
54. Adelman A.G., McLoughlin M.J., Marquis Y., Auger P., and Wigle E.D. Left ventricular cineangiographic observations in muscular subaortic stenosis. Am J Cardiol 24 (1969) 689-697
55. Spirito P., and Maron B.J. Patterns of systolic anterior motion of the mitral valve in hypertrophic cardiomyopathy: assessment of two-dimensional echocardiography. Am J Cardiol 54 (1984) 1039-1046
56. Maron B.J., Harding A.M., Spirito P., Roberts W.C., and Waller B.F. Systolic anterior motion of the posterior mitral leaflet: a previously unrecognized course of dynamic subaortic obstruction in patients with hypertrophic cardiomyopathy. Circulation 68 (1983) 282-293
57. Falicov R.E., Resnekov L., Bharati S., and Lev M. Mid-ventricular obstruction: a variant of obstructive cardiomyopathy. Am J Cardiol 37 (1976) 432-437
58. Fighali S., Krajcer Z., Edelman S., and Leachman R.D. Progression of hypertrophic cardiomyopathy into a hypokinetic left ventricle: higher incidence in patients with midventricular obstruction. J Am Coll Cardiol 9 (1987) 288-294
59. Klues H.G., Roberts W.C., and Maron B.J. Anomalous insertion of papillary muscle directly into anterior mitral leaflet in hypertrophic cardiomyopathy: significance in producing left ventricular outflow obstruction. Circulation 84 (1991) 1188-1197
60. Grigg L.E., Wigle E.D., Williams W.G., Daniel L.B., and Rakowski H. Transesophageal Doppler echocardiography in obstructive hypertrophic cardiomyopathy: clarification of pathophysiology and importance in intraoperative decision making. J Am Coll Cardiol 20 (1992) 42-52
61. Spirito P., and Maron B.J. Significance of left ventricular outflow tract cross-sectional area in hypertrophic cardiomyopathy: a two-dimensional echocardiographic assessment. Circulation 67 (1983) 1100-1108
62. Klues H.G., Maron B.J., Dollar A.L., and Roberts W.C. Diversity of structural mitral valve alterations in hypertrophic cardiomyopathy. Circulation 85 (1992) 1651-1660
63. Cooley D.A. Surgical techniques for hypertrophic left ventricular obstructive myopathy including mitral valve placation. J Cardiovasc Surg 6 (1991) 29-33
64. Roberts W.C. Operative treatment of hypertrophic obstructive cardiomyopathy. The case against mitral valve replacement. Am J Cardiol 32 (1973) 377-381
65. McIntosh C.L., and Maron B.J. Current operative treatment of obstructive hypertrophic cardiomyopathy. Circulation 78 (1988) 487-495
66. Jenni R., Ruffmann K., Vieli A., Anliker M., and Krayenbuchl H.P. Dynamics of aortic flow in hypertrophic cardiomyopathy. Eur Heart J 6 (1985) 391-398
67. Sugrue D.D., McKenna W.J., Dickie S., et al. Relation between left ventricular gradient and relative stroke volume ejection in early and late systole in hypertrophic cardiomyopathy: assessment with radionuclide cineangiography. Br Heart J 52 (1984) 602-609
68. Cannon R.O., Schenke W.H., Maron B.J., et al. Differences in coronary flow and myocardial metabolism at rest and during pacing between patients with obstructive and patients with nonobstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 10 (1987) 53-62
69. Cecchi F., Olivotto I., Gistri R., Lorenzoni R., Chiriatti G., and Camici P.G. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med 349 (2003) 1027-1035
70. Jeanrenaud X., Goy J.J., and Kappenberger L. Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy. Lancet 339 (1992) 1318-1323
71. Slade A.K.B., Sadoul N., Shapiro L., et al. DDD pacing in hypertrophic cardiomyopathy: a multicentre clinical experience. Heart 75 (1996) 44-49
72. Fananapazir L., Epstein N.D., Curiel R.V., Panza J.A., Tripodi D., and McAreavey D. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy. Circulation 90 (1994) 2731-2742
73. Kappenberger L., Linde C., Daubert C., et al. Pacing in hypertrophic obstructive cardiomyopathy. A randomized crossover study. Eur Heart J 18 (1997) 1249-1256
74. Nishimura R.A., Trusty J.M., Hayes D.L., et al. Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind cross-over study. J Am Coll Cardiol 29 (1997) 435-441
75. Maron B.J., Nishimura R.A., McKenna W.J., Rakowski H., Josephson M.E., and Kieval R.S. Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy: a randomized, double-blind cross-over study (M-PATHY). Circulation 99 (1999) 2927-2933
76. Linde C., Gadler F., Kappenberger L., and Rydén L. Placebo effect of pacemaker implantation in obstructive hypertrophic cardiomyopathy. Am J Cardiol 83 (1999) 903-907
77. Maron B.J. Controversies in cardiovascular medicine. Is septal ablation preferable to surgical myomectomy for obstructive hypertrophic cardiomyopathy? Surgical myectomy remains the primary treatment option for severely symptomatic patients with obstructive hypertrophic cardiomyopathy. Circulation 116 (2007) 196-206
78. Fifer M.A. Most fully informed patients choose septal ablation over septal myectomy. Circulation 116 (2007) 207-216
79. Sherrid M.V., Gunsberg D.D.Z., Moldenhauer S., and Pearle G. Systolic anterior motion begins at low left ventricular outflow tract velocity in obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 36 (2000) 1344-1354
80. Breithardt O.-A., Beer G., Stolle B., et al. Mid systolic septal deceleration in hypertrophic cardiomyopathy: clinical value and insights into the pathophysiology of outflow tract obstruction by tissue Doppler echocardiography. Heart 91 (2005) 379-380
81. Sherrid M.V., Gunsburg D.Z., and Pearle G. Mid-systolic drop in left ventricular ejection velocity in obstructive hypertrophic cardiomyopathy-the lobster claw abnormality. J Am Soc Echocardiogr 10 (1997) 707-712
82. Yock P.G., Hatle L., and Popp R.L. Patterns and timing of Doppler-detected intracavitary and aortic flow in hypertrophic cardiomyopathy. J Am Coll Cardiol 8 (1986) 1047-1058
83. Sherrid M.V., Chu C.K., Delia E., Mograder A., and Dwyer Jr. E.M. An echocardiography study of the fluid mechanics of obstruction in hypertrophic cardiomyopathy. J Am Coll Cardiol 22 (1993) 816-825
84. Sasson Z., Henderson M., Wilansky S., Rakowski H., and Wigle E.D. Causal relation between the pressure gradient and left ventricular ejection time in hypertrophic cardiomyopathy. J Am Coll Cardiol 13 (1989) 1275-1279
85. Pollick C., Rakowski H., and Wigle E.D. Muscular subaortic stenosis: the quantitative relationship between systolic anterior motion and the pressure gradient. Circulation 69 (1984) 43-49
86. Panza J.A., Petrone R.K., Fananapazir L., and Maron B.J. Utility of continuous wave Doppler echocardiography in the noninvasive assessment of left ventricular outflow tract pressure gradient in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 29 (1982) 91-99
87. Spirito P., Maron B.J., and Rosing D.R. Morphologic determinants of hemodynamic state following ventricular septal myotomy-myectomy in patients with hypertrophic cardiomyopathy: M-mode and two-dimensional echocardiographic assessment. Circulation 70 (1984) 984-995
88. Maron B.J., Gottdiener J.S., Arce J., Rosing D.R., Wesley Y.E., and Epstein S.E. Dynamic subaortic obstruction in hypertrophic cardiomyopathy: analysis by pulsed Doppler echocardiography. J Am Coll Cardiol 6 (1985) 1-15
89. Wigle E.D. Muscular subaortic stenosis: the clinical syndrome with additional evidence of ventricular septal hypertrophy. Cardiomyopathies (CIBA Symposium) (1964), J & S Churchill, Ltd., London 49-59
90. Maron M.S., Olivotto I., Betocchi S., et al. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med 348 (2003) 295-303
91. Autore C., Bernabò P., Barillà C.S., Bruzzi P., and Spirito P. The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms. J Am Coll Cardiol 45 (2005) 1078-1080
92. Elliott P.M., Gimeno J.R., Tomé M.T., et al. Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy. Eur Heart J 27 (2006) 1933-1941
93. Ommen S.R., Maron B.J., Olivotto I., et al. Long term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 46 (2005) 470-476
94. Woo A., Williams W.G., Choi R., et al. Clinical and echocardiographic determinants of long-term survival after surgical myectomy in obstructive hypertrophic cardiomyopathy. Circulation 111 (2005) 2033-2041
95. Maron B.J., Dearani J.A., Ommen S.R., et al. The case for surgery in obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 44 (2004) 2044-2053
96. Cannon R.O., McIntosh C.L., Schenke W.H., Maron B.J., Bonow R.O., and Epstein S.E. Effect of surgical reduction of left ventricular outflow obstruction on hemodynamics, coronary flow, and myocardial metabolism in hypertrophic cardiomyopathy. Circulation 79 (1989) 766-775
97. Diodati J., Schenke W., Waclawiw M.A., McIntosh C.L., and Gannon R.O. Predictors of exercise benefit after operative relief of left ventricular outflow obstruction by the myotomy-myectomy procedure in hypertrophic cardiomyopathy. Am J Cardiol 69 (1992) 1617-1622
98. McLeod C.J., Ommen S.R., Ackerman M.J., et al. Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy. Eur Heart J 28 (2007) 2583-2588
99. Gietzen F.H., Leuner C.J., Obergassel L., Strunk-Mueller C., and Kuhn H. Role of transcoronary ablation of septal hypertrophy in patients with hypertrophic cardiomyopathy, New York Heart Association functional class III or IV, and outflow obstruction only under provocable conditions. Circulation 106 (2002) 454-459
100. Maron B.J., Olivotto I., and Maron M.S. The dilemma of left ventricular outflow tract obstruction and sudden death in hypertrophic cardiomyopathy: do patients with gradients really deserve prophylactic defibrillators (editorial)?. Eur Heart J 27 (2006) 1895-1897